Hopkins tests Brain-Targeting lithium for Alzheimer's
NCT ID NCT07459959
Summary
This early-stage study is checking if a form of lithium called lithium orotate is safe and can get into the brain in people with early Alzheimer's disease. Over 9 weeks, 40 participants will take either the lithium pill or a placebo to see if it's well-tolerated and reaches the spinal fluid. The main goals are to see if people can stick with the study plan and to measure lithium levels in the brain, not to treat symptoms yet.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.